Spain's Zeltia SA Jumps on Ovarian Cancer Drug News
MADRID, Aug 7 (Reuters) - Spanish pharmaceutical firm Zeltia said on Thursday it would seek regulatory approval for the use of its Yondelis drug to treat ovarian cancer after good results from final trials, sending the stock soaring.